
    
      The device has the CE Mark and will be used in the indication for which it is approved.

      Up to 60 patients will be assigned to the study (up to 30 patients for Orbix procedure, and
      up to 30 patients without Orbix procedure (only routine reduction/symmetrisation). Patients
      will return to the clinic for follow-up at 1, 3, 6, 12 & 24 months (last visit will be
      optional).
    
  